Douglas Reed

Douglas Reed

Directeur/Membre du Conseil chez
Viamet Pharmaceuticals Corp.
72 ans
Health Technology
Finance
Consumer Services

Profil

Douglas W.
Reed
currently works at Innocrin Pharmaceuticals Holdings LLC, as Chairman from 2014, Viamet Pharmaceuticals, Inc., as Director from 2007, Contego Medical, Inc., as Director, Viamet Pharmaceuticals Corp., as Director from 2011, Southeast BIO, as Director from 2009, Innocrin Pharmaceuticals, Inc., as Director, Standard Bariatrics, Inc., as Director, Qpex Biopharma, Inc., as Director, Hatteras Venture Affiliates III LP, as General Partner, and Hatteras Venture Partners, as General Partner from 2007.
Dr. Reed also formerly worked at Star Equity Holdings, Inc., as Director from 2000 to 2009, PhaseBio Pharmaceuticals, Inc., as Director, TetraLogic Pharmaceuticals Corp., as Independent Director from 2010 to 2016, SpineAlign Medical, Inc., as Director, BlinkBio, Inc., as Director, NeuroTronik, Inc., as Director, Sideris Pharmaceuticals, Inc., as Director, Gilead Connecticut, Inc., as Director from 2001 to 2010, Vector Asset Management, Inc., as Managing Director, Embrella Cardiovascular, Inc., as Director from 2009 to 2011, First National Bank of Crossett (Arkansas), as Director, NPS Pharmaceuticals, Inc., as Vice President-Business Development from 1996 to 1997, GelTex Pharmaceuticals, Inc., as Vice President-Business Development in 1999, GSK Equity Investments Ltd, as Principal, and the University of Washington, as Assistant Professor in 1983.
Dr. Reed received his undergraduate degree in 1977 and doctorate degree in 1978 from the University of Missouri-Kansas City and Masters Business Admin degree in 1989 from The Wharton School of the University of Pennsylvania.

Postes actifs de Douglas Reed

SociétésPosteDébut
Directeur/Membre du Conseil -
Président 01/01/2014
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Southeast BIO
Directeur/Membre du Conseil 01/01/2009
Directeur/Membre du Conseil 01/05/2007
Corporate Officer/Principal -
Directeur/Membre du Conseil 01/12/2011
Private Equity Investor 01/01/2007
░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -

Anciens postes connus de Douglas Reed

SociétésPosteFin
░░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
Voir l'expérience en détail de Douglas Reed

Formation de Douglas Reed

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

75

Relations au 1er degré

27

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées27

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Finance

Southeast BIO

Finance

Commercial Services

Consumer Services

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Douglas Reed
-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇